Pabinafusp alfa Recruiting Phase 3 Trials for Mucopolysaccharidosis Type II (MPS II) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04573023A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)